- Home
- FVR vs KOD Comparison
FVR vs KOD Comparison
Compare FVR & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVR
- KOD
- Stock Information
- Founded
- FVR 2016
- KOD 2009
- Country
- FVR United States
- KOD United States
- Employees
- FVR N/A
- KOD N/A
- Industry
- FVR
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FVR
- KOD Health Care
- Exchange
- FVR NYSE
- KOD Nasdaq
- Market Cap
- FVR 227.7M
- KOD 198.4M
- IPO Year
- FVR 2024
- KOD 2018
- Fundamental
- Price
- FVR $12.84
- KOD $8.84
- Analyst Decision
- FVR Hold
- KOD Hold
- Analyst Count
- FVR 5
- KOD 3
- Target Price
- FVR $16.80
- KOD $9.00
- AVG Volume (30 Days)
- FVR 221.8K
- KOD 534.9K
- Earning Date
- FVR 08-13-2025
- KOD 08-13-2025
- Dividend Yield
- FVR 6.70%
- KOD N/A
- EPS Growth
- FVR N/A
- KOD N/A
- EPS
- FVR N/A
- KOD N/A
- Revenue
- FVR $60,901,000.00
- KOD N/A
- Revenue This Year
- FVR $17.29
- KOD N/A
- Revenue Next Year
- FVR $8.41
- KOD N/A
- P/E Ratio
- FVR N/A
- KOD N/A
- Revenue Growth
- FVR 15.85
- KOD N/A
- 52 Week Low
- FVR $10.61
- KOD $1.92
- 52 Week High
- FVR $19.76
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- FVR N/A
- KOD 84.50
- Support Level
- FVR N/A
- KOD $5.00
- Resistance Level
- FVR N/A
- KOD $5.73
- Average True Range (ATR)
- FVR 0.00
- KOD 0.70
- MACD
- FVR 0.00
- KOD 0.42
- Stochastic Oscillator
- FVR 0.00
- KOD 99.61
About FVR FRONTVIEW REIT INC
FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.